Wu Tsai Neurosciences Institute

The lab’s second crop of pilot awards will foster research in visual attention, the neurophysiology of exercise, and therapies for autism and mild cognitive impairment associated with aging.

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this complex disease will likely need multiple complementary treatments.

In which physician-scientist Marion Buckwalter shares the remarkable advances we've seen in stroke care in recent decades, thanks to long-standing national support for curiosity-driven research

Scientists in the lab of chemical engineer Monther Abu-Remaileh are uncovering the cellular functions that go awry in degenerative brain disorders and identifying therapies that could treat them.

A decade ago, three generations of Stanford scientists banded together to publish a landmark study on one of the brain’s most prevalent structures. Today, Wu Tsai Neurosciences Institute researchers are discovering that myelin is key to just about every aspect of neurological health.

In which anesthesiologist Martin Angst shares how studying the biology of recovery may reveal why some aging brains withstand stress while others quietly unravel.

Research from the Giocomo lab finds that mice create neural maps of the location of rewards, distinct from the well-known hippocampal maps of an animal's location in space.

In which Anthony Wagner and Beth Mormino share what they are learning from the Stanford Aging and Memory Study about the nature of healthy brain aging.

This week on the podcast, Stanford cell biologist Brad Zuchero takes us on a tour of the frontiers of glia-science

This week on the podcast, Stanford psychiatry professor Erin Gibson joins us again to share the latest findings on sleep, myelin, and neurodegenerative disease.